02.01.2015 Views

Antibiotikaprofylax vid kirurgiska ingrepp - SBU

Antibiotikaprofylax vid kirurgiska ingrepp - SBU

Antibiotikaprofylax vid kirurgiska ingrepp - SBU

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Table 4.5.3 Closed fractures; duration of prophylaxis and comparison<br />

of different antibiotics.<br />

Author<br />

Year<br />

Reference<br />

Country<br />

Study design<br />

Population<br />

characteristics<br />

Intervention/<br />

Method (I)<br />

Control (C) Results Withdrawal<br />

Drop outs<br />

Study quality<br />

and relevance<br />

Comments<br />

Buckley<br />

1990<br />

[10]<br />

Canada<br />

RCT double<br />

blind. Included<br />

power calculation<br />

Hip fracture surgery.<br />

Excluded: Pre-op ab<br />

for >7 days<br />

I: Cefazolin<br />

2 g at induction<br />

of anesthesia<br />

+<br />

placebo<br />

x 3 x I (n=83)<br />

C: Cefazolin 2 g at<br />

induction of anesthesia<br />

+ 2 g x 3 x I (n=121)<br />

Deep wound infection<br />

I: 0/83<br />

C: 0/121<br />

ns<br />

Superficial wound<br />

infection<br />

I: 2/121 (1.6%)<br />

C: 2/83 (2.4%)<br />

ns<br />

40/352 High<br />

Included in<br />

Cochrane review<br />

[5]. Low event rate<br />

Garcia<br />

1991<br />

[11]<br />

Spain<br />

RCT single blind.<br />

Includes power calculation<br />

Closed fractures operation<br />

with metal devices.<br />

Excluded: Total hip replacement,<br />

infection in area.<br />

Follow-up “on demand”<br />

I1: Cefonicid<br />

(t1/2=4.5 h)<br />

2 g one dose<br />

at induction<br />

of anesthesia<br />

(n=474)<br />

I2: Cefamandole<br />

2 g<br />

(t1/2=48 min)<br />

at induction<br />

of anesthesia,<br />

2 h and 8 h<br />

after (3 doses)<br />

(n=510)<br />

I3: Cefamandole<br />

at<br />

induction of<br />

anesthesia,<br />

2 h, 8 h, 14 h,<br />

24 h after<br />

(5 doses)<br />

(n=505)<br />

Wound infection<br />

(deep and superficial)<br />

I1: 7/474 (1.5%)<br />

I2: 10/510 (2%)<br />

I3: 10/505 (2%)<br />

ns<br />

Drop outs or lost<br />

to follow-up not<br />

mentioned<br />

High<br />

Included in<br />

Cochrane review<br />

[5]. Follow-up<br />

unclear<br />

The table continues on the next page<br />

288 antibiotikaprofylax <strong>vid</strong> <strong>kirurgiska</strong> <strong>ingrepp</strong> KAPITEL 4 • den systematiska litteraturöversikten<br />

289

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!